Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis

Physicians are challenged by the recognition and treatment of older patients with rheumatoid arthritis (RA). The aim of this case-control study was to evaluate the retention and safety of conventional disease-modifying anti-rheumatic drugs in older patients with RA.In this observational case-control...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2020-04, Vol.99 (16), p.e19696
Main Authors: Alpay-Kanitez, Nilüfer, Pehlivan, Özlem, Omma, Ahmet, Can-Sandikçi, Sevinç, Girgin, Sinem, İçaçan, Ozan Cemal, Çelik, Selda, Bes, Cemal
Format: Article
Language:English
Subjects:
Age Factors
Aged
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Case-Control Studies
Female
Humans
Male
Medication Adherence
Middle Aged
Observational Study
Patient Safety
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Physicians are challenged by the recognition and treatment of older patients with rheumatoid arthritis (RA). The aim of this case-control study was to evaluate the retention and safety of conventional disease-modifying anti-rheumatic drugs in older patients with RA.In this observational case-control study, we assessed older patients with RA (≥65 years) who were diagnosed in 3 different rheumatology centers from Turkey. Patients were divided as to those aged ≥65 years (elderly rheumatoid arthritis [ERA]) and those aged
ISSN:0025-7974
1536-5964
DOI:10.1097/MD.0000000000019696